A Dedicated Celiac Disease Program Improves Celiac Quality Care Metrics and Short-Term Outcomes in Real Life
Open Access
- 5 March 2024
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 69 (4) , 1118-1124
Abstract
Background and Aims Dedicated multidisciplinary programs in gastroenterology are emerging with the goal to improve care. There is little information about the effects of a celiac disease program on disease-related quality care metrics and outcomes. We aimed to compare quality care metrics, symptom resolution, and serological response among patients diagnosed and treated in a celiac disease program with a standard of care cohort. Methods We performed a retrospective cohort study with adult celiac disease patients. We divided patients into two groups: celiac disease patients treated in our program and those treated by gastroenterologists not affiliated with the program (standard of care). We abstracted data from electronical medical records and compared frequency at which guideline-driven quality care metrics were obtained, assessed symptom resolution, and serological response based on IgA anti-tissue transglutaminase levels. Results We included 340 patients, 120 in the celiac disease program (89 women) and 220 (166 women) in the standard of care. Frequency of quality care metrics implementation in program patients was significantly greater for all variables (p < 0.0005). Diarrhea resolved in 38/46 (82.6%) in the CD program and 63/98 (64.2%) in the standard of care after starting a gluten-free diet (p = .025); bloating also resolved significantly more often in the former (26/34) than the latter (31/58; p = 0.03). Otherwise, there were no significant differences in resolution of clinical symptoms or serological response. Conclusion A celiac disease program improves celiac-related quality care metrics and may improve outcomes such as diarrhea resolution compared to standard of care.Keywords
This publication has 23 references indexed in Scilit:
- Association Between Celiac Disease and Mortality Risk in a Swedish PopulationJAMA, 2020
- AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease—Changing Utility of Serology and Histologic Measures: Expert ReviewGastroenterology, 2019
- Identifying and improving adherence to the gluten-free diet in people with coeliac diseaseProceedings of the Nutrition Society, 2019
- Coeliac diseaseThe Lancet, 2018
- Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease PatientsAmerican Journal of Gastroenterology, 2016
- ACG Clinical Guidelines: Diagnosis and Management of Celiac DiseaseAmerican Journal of Gastroenterology, 2013
- Patients With Celiac Disease Are Not Followed Up AdequatelyClinical Gastroenterology and Hepatology, 2012
- Five year time course of celiac disease serology during gluten free diet: results of a community based “CD-Watch” programDigestive and Liver Disease, 2010
- Mucosal Recovery and Mortality in Adults With Celiac Disease After Treatment With a Gluten-Free DietAmerican Journal of Gastroenterology, 2010
- National Institutes of Health Consensus Development Conference statement on Celiac Disease, June 28–30, 2004Gastroenterology, 2005